Lexington Partners is a private investment firm with approximately $33 billion in committed capital for private equity investing. Lexington Partners focuses its activity on secondary investments, equity co-investments, and fund investments. Lexington's primary business is its secondary private equity group, which seeks to provide liquidity for private equity fund interests. Lexington's co-investment group looks to invest $10 to $100 million alongside private equity sponsors in a variety of sectors. Lexington Partners was formed in 1994 and is based in New York City.
Join Mergr to view the latest updates and news from New York-based Lexington Partners.
In the last 3 years, Lexington Partners has acquired 1 company. It has also invested in 1 other.
Lexington Partners’ most common sectors for investment are medical products (25%) and aerospace (13%). The Firm’s most common investment types include buyout (lbo, mbo, mbi) (38%) and going private (25%). In total, Lexington Partners has invested in 6 US states and 3 different countries. Its largest (disclosed) acquisition occurred in 2007 when it acquired Bausch & Lomb for $4.5B.
In the last 3 years, Lexington Partners has exited 1 company. The Firm’s most common exit type is trade sale (60%). Lexington Partners’ largest (disclosed) exit occurred in 2013 when it sold Bausch & Lomb for $8.7B.
Join Mergr to view Lexington Partners’ full profile and discover more mega-sized private equity firms just like it.
No obligation. Cancel anytime.